Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:50 UTC |
---|
Update Date | 2022-03-07 02:51:44 UTC |
---|
HMDB ID | HMDB0014754 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Candoxatril |
---|
Description | Candoxatril is only found in individuals that have used or taken this drug. It is the orally-active prodrug of candoxatrilat (UK-73967), the active enantiomer of candoxatrilat (UK-69578), a potent neutral endopeptidase (NEP) inhibitor used in the treatment of chronic heart failure.Neutral endopeptidase inhibitors such as Candoxatril have a dual mechanism of action. They inhibit two metalloprotease enzymes, neutral endopeptidase and ACE, resulting in an increased availability of natriuretic peptides that exhibit vasodilatory effects and, possibly, tissue protective effects. |
---|
Structure | COCCOC[C@H](CC1(CCCC1)C(=O)N[C@H]1CC[C@H](CC1)C(O)=O)C(=O)OC1=CC2=C(CCC2)C=C1 InChI=1S/C29H41NO7/c1-35-15-16-36-19-23(27(33)37-25-12-9-20-5-4-6-22(20)17-25)18-29(13-2-3-14-29)28(34)30-24-10-7-21(8-11-24)26(31)32/h9,12,17,21,23-24H,2-8,10-11,13-16,18-19H2,1H3,(H,30,34)(H,31,32)/t21-,23-,24+/m0/s1 |
---|
Synonyms | Value | Source |
---|
4-({1-[(S)-2-(indan-5-yloxycarbonyl)-3-(2-methoxy-ethoxy)-propyl]-cyclopentanecarbonyl}-amino)-cyclohexanecarboxylic acid | ChEBI | [4(S)-cis]-4-[[[1-[3-[(2,3-Dihydro-1H-indeb5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]cyclohexanecarboxylic acid | ChEBI | 4-({1-[(S)-2-(indan-5-yloxycarbonyl)-3-(2-methoxy-ethoxy)-propyl]-cyclopentanecarbonyl}-amino)-cyclohexanecarboxylate | Generator | [4(S)-cis]-4-[[[1-[3-[(2,3-Dihydro-1H-indeb5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]cyclohexanecarboxylate | Generator |
|
---|
Chemical Formula | C29H41NO7 |
---|
Average Molecular Weight | 515.6383 |
---|
Monoisotopic Molecular Weight | 515.288302671 |
---|
IUPAC Name | (1s,4s)-4-{1-[(2S)-3-(2,3-dihydro-1H-inden-5-yloxy)-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentaneamido}cyclohexane-1-carboxylic acid |
---|
Traditional Name | candoxatril |
---|
CAS Registry Number | 118785-03-8 |
---|
SMILES | COCCOC[C@H](CC1(CCCC1)C(=O)N[C@H]1CC[C@H](CC1)C(O)=O)C(=O)OC1=CC2=C(CCC2)C=C1 |
---|
InChI Identifier | InChI=1S/C29H41NO7/c1-35-15-16-36-19-23(27(33)37-25-12-9-20-5-4-6-22(20)17-25)18-29(13-2-3-14-29)28(34)30-24-10-7-21(8-11-24)26(31)32/h9,12,17,21,23-24H,2-8,10-11,13-16,18-19H2,1H3,(H,30,34)(H,31,32)/t21-,23-,24+/m0/s1 |
---|
InChI Key | ZTWZVMIYIIVABD-OEMFJLHTSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as indanes. Indanes are compounds containing an indane moiety, which consists of a cyclopentane fused to a benzene ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Indanes |
---|
Sub Class | Not Available |
---|
Direct Parent | Indanes |
---|
Alternative Parents | |
---|
Substituents | - Indane
- Fatty acid ester
- Dicarboxylic acid or derivatives
- Fatty amide
- Fatty acyl
- Carboxamide group
- Secondary carboxylic acid amide
- Carboxylic acid ester
- Ether
- Dialkyl ether
- Carboxylic acid
- Carboxylic acid derivative
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Carbonyl group
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Aromatic homopolycyclic compound
|
---|
Molecular Framework | Aromatic homopolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.0022 g/L | Not Available | LogP | 3.7 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Candoxatril,1TMS,isomer #1 | COCCOC[C@H](CC1(C(=O)N[C@H]2CC[C@@H](C(=O)O[Si](C)(C)C)CC2)CCCC1)C(=O)OC1=CC=C2CCCC2=C1 | 3935.2 | Semi standard non polar | 33892256 | Candoxatril,1TMS,isomer #2 | COCCOC[C@H](CC1(C(=O)N([C@H]2CC[C@@H](C(=O)O)CC2)[Si](C)(C)C)CCCC1)C(=O)OC1=CC=C2CCCC2=C1 | 4063.8 | Semi standard non polar | 33892256 | Candoxatril,2TMS,isomer #1 | COCCOC[C@H](CC1(C(=O)N([C@H]2CC[C@@H](C(=O)O[Si](C)(C)C)CC2)[Si](C)(C)C)CCCC1)C(=O)OC1=CC=C2CCCC2=C1 | 3960.0 | Semi standard non polar | 33892256 | Candoxatril,2TMS,isomer #1 | COCCOC[C@H](CC1(C(=O)N([C@H]2CC[C@@H](C(=O)O[Si](C)(C)C)CC2)[Si](C)(C)C)CCCC1)C(=O)OC1=CC=C2CCCC2=C1 | 3752.0 | Standard non polar | 33892256 | Candoxatril,2TMS,isomer #1 | COCCOC[C@H](CC1(C(=O)N([C@H]2CC[C@@H](C(=O)O[Si](C)(C)C)CC2)[Si](C)(C)C)CCCC1)C(=O)OC1=CC=C2CCCC2=C1 | 4730.7 | Standard polar | 33892256 | Candoxatril,1TBDMS,isomer #1 | COCCOC[C@H](CC1(C(=O)N[C@H]2CC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)CC2)CCCC1)C(=O)OC1=CC=C2CCCC2=C1 | 4177.0 | Semi standard non polar | 33892256 | Candoxatril,1TBDMS,isomer #2 | COCCOC[C@H](CC1(C(=O)N([C@H]2CC[C@@H](C(=O)O)CC2)[Si](C)(C)C(C)(C)C)CCCC1)C(=O)OC1=CC=C2CCCC2=C1 | 4288.4 | Semi standard non polar | 33892256 | Candoxatril,2TBDMS,isomer #1 | COCCOC[C@H](CC1(C(=O)N([C@H]2CC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)CC2)[Si](C)(C)C(C)(C)C)CCCC1)C(=O)OC1=CC=C2CCCC2=C1 | 4408.7 | Semi standard non polar | 33892256 | Candoxatril,2TBDMS,isomer #1 | COCCOC[C@H](CC1(C(=O)N([C@H]2CC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)CC2)[Si](C)(C)C(C)(C)C)CCCC1)C(=O)OC1=CC=C2CCCC2=C1 | 4132.6 | Standard non polar | 33892256 | Candoxatril,2TBDMS,isomer #1 | COCCOC[C@H](CC1(C(=O)N([C@H]2CC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)CC2)[Si](C)(C)C(C)(C)C)CCCC1)C(=O)OC1=CC=C2CCCC2=C1 | 4847.2 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Candoxatril GC-MS (Non-derivatized) - 70eV, Positive | splash10-001i-8903400000-268da98bf001b2697ad3 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Candoxatril GC-MS (1 TMS) - 70eV, Positive | splash10-00ea-9701230000-415d420bb3afba46e038 | 2017-10-06 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Candoxatril 90V, Positive-QTOF | splash10-00pl-9200000000-bc11c66d3ece45e09e88 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Candoxatril 75V, Positive-QTOF | splash10-00pi-9600000000-83441da8ede7797f50e7 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Candoxatril 45V, Positive-QTOF | splash10-057r-2900000000-60fd63861087a3fe92d9 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Candoxatril 60V, Positive-QTOF | splash10-057i-6900000000-d1197406ad3d8cefddfa | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Candoxatril 45V, Positive-QTOF | splash10-057r-2900000000-0e86e71ecc29989958e8 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Candoxatril 15V, Positive-QTOF | splash10-053r-0009000000-f592f37f904e3e76bf19 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Candoxatril 30V, Positive-QTOF | splash10-0569-1986000000-e7ba3bddb330c80b7ce9 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Candoxatril 10V, Positive-QTOF | splash10-014i-0714950000-0d88710626c10ccc6895 | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Candoxatril 20V, Positive-QTOF | splash10-014i-1924400000-1212988199020b7a6e78 | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Candoxatril 40V, Positive-QTOF | splash10-015c-4951100000-c7b3c19e54fc433cebc6 | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Candoxatril 10V, Negative-QTOF | splash10-03di-2302690000-82a62f70e9d322ce04e4 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Candoxatril 20V, Negative-QTOF | splash10-0h60-1409510000-c92b3392f22113ddb47a | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Candoxatril 40V, Negative-QTOF | splash10-001i-6910000000-a9c7701cff60595f6454 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Candoxatril 10V, Positive-QTOF | splash10-014i-0001390000-c54e9b5c348fb0757710 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Candoxatril 20V, Positive-QTOF | splash10-017i-3386960000-eb7472fe7ae253206129 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Candoxatril 40V, Positive-QTOF | splash10-0170-6921420000-e5f0c1c9c0d663cf9dff | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Candoxatril 10V, Negative-QTOF | splash10-0bt9-0010910000-64ff1f2df639c0ba09b2 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Candoxatril 20V, Negative-QTOF | splash10-000f-0736910000-09ca3f3a4172911e6edc | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Candoxatril 40V, Negative-QTOF | splash10-01ox-8912370000-d08f092f5a2aef1c655f | 2021-10-11 | Wishart Lab | View Spectrum |
|
---|